Comment on CMS-2026-1255-0001
PWSA | USA - Prader-Willi Syndrome AssociationSupportAdvocacy
Summary: The Prader-Willi Syndrome Association | USA (PWSA | USA) supports CMS's efforts to modernize prior authorization processes but urges specific protections for patients with rare diseases. They argue that prior authorization delays can lead to dangerous clinical consequences, unnecessary repeated blood draws for patients with behavioral challenges, and significant administrative burdens on families and providers.
See attached file(s)